OptimizeRx CEO, William Febbo, to Speak at Bank of America 4th Annual HCIT and Digital Health Symposium Today, December 9, 20...
09 Dicembre 2020 - 1:31PM
OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital
health solutions for life science companies, physicians and
patients, has been invited to participate at the Bank of America
4th Annual HCIT and Digital Health Symposium on December 9-10.
OptimizeRx CEO William Febbo will be a speaker on the panel,
“Trends in Tech-Enabled Rx Supply Chain.” The panel will be
moderated by Rajat Bhatia, a Director in Global Healthcare
Investment Banking at BofA Securities, and Justin Walter, Head of
Healthcare Services Investment Banking at BofA Securities.
Event attendees will include healthcare-focused Bank of America
corporate and commercial clients, executives from healthcare
services and digital health companies, as well as private equity,
venture capital and crossover equity investors.
About OptimizeRxOptimizeRx is a digital health
company that provides communications solutions for life science
companies, physicians and patients. Connecting over half of
healthcare providers in the US and millions of patients through a
proprietary network, the OptimizeRx digital health platform helps
patients afford and stay on medications. The platform unlocks new
patient and physician touchpoints for life science companies along
the patient journey, from point-of-care, to retail pharmacy,
through mobile patient engagement.For more information, follow the
company on Twitter, LinkedIn or
visit www.optimizerx.com.
Important Cautions Regarding Forward Looking
StatementsThis press release contains forward-looking
statements within the definition of Section 27A of the Securities
Act of 1933, as amended, and such as in section 21E of the
Securities Act of 1934, as amended. These forward-looking
statements should not be used to make an investment decision. The
words 'estimate,' 'possible' and 'seeking' and similar expressions
identify forward-looking statements, which speak only as to the
date the statement was made. The company undertakes no obligation
to publicly update or revise any forward-looking statements,
whether because of new information, future events, or otherwise.
Forward-looking statements are inherently subject to risks and
uncertainties, some of which cannot be predicted, or quantified.
Future events and actual results could differ materially from those
set forth in, contemplated by, or underlying the forward-looking
statements. The risks and uncertainties to which forward-looking
statements are subject include, but are not limited to, the effect
of government regulation, competition, and other material
risks.
Company Contact Doug Baker, CFOTel (248)
651-6568 x807 dbaker@optimizerx.com
Media Contact Maira Alejandra, Media Relations
ManagerTel (754) 245-7070 malejandra@optimizerx.com
Investor Relations Contact Ron Both or Grant
StudeCMA Investor RelationsTel (949) 432-7557 oprx@cma.team
Grafico Azioni OptimizeRx (NASDAQ:OPRX)
Storico
Da Giu 2024 a Lug 2024
Grafico Azioni OptimizeRx (NASDAQ:OPRX)
Storico
Da Lug 2023 a Lug 2024